InvestorsHub Logo
Followers 4
Posts 753
Boards Moderated 0
Alias Born 04/18/2017

Re: needsomestock post# 2061

Wednesday, 12/19/2018 11:21:24 AM

Wednesday, December 19, 2018 11:21:24 AM

Post# of 54915
PRED owns a little over 50% of Juneau.

Our ARTguide™ test was developed by Juneau Biosciences, LLC. We currently own just over fifty percent of Juneau. We have an exclusive license with Juneau to market Juneau’s patented molecular diagnostics for use in the prognosis and monitoring of endometriosis in the infertility and
pelvic pain markets